Diaceutics plc (DIUXF)

Overview

Diaceutics PLC is a pioneering company in the realm of diagnostic commercialisation, delivering comprehensive data, analytics, and implementation services to pharmaceutical enterprises globally. Its foundation was laid in 2005, and since then, it has established its headquarters in Belfast, United Kingdom. The cornerstone of its innovation is the DXRX platform, a multifaceted ecosystem designed to streamline the pathway of precision medicine diagnostics by fostering collaboration among labs, pharmaceutical, and diagnostic companies. This platform not only facilitates access to an extensive range of diagnostic testing data but also propels the commercialisation and development processes of therapeutics and companion diagnostics. Through its services, Diaceutics PLC aims to bridge the gaps in the precision medicine marketplace, ensuring that patients receive timely and accurate diagnoses to guide their treatment options effectively.

Products and Services

Diaceutics PLC offers a comprehensive suite of products and services designed to address various facets of precision medicine diagnostics:

• DXRX Data Solutions: These include access to a wide array of diagnostic testing data from a network of laboratories. Key offerings under this category are:
  • DXRX Signal: Provides insights and analytics from laboratory data to identify trends and opportunities.
  • Lab Mapping: A service that maps out laboratory capabilities and testing availability worldwide.
  • Testing Dashboard: Offers real-time monitoring of testing volumes and patterns.
  • Physician Mapping: Assists in identifying and connecting with physicians knowledgeable about specific biomarkers and testing.
• DXRX Marketplace Solutions: Facilitates a dynamic marketplace for labs, pharmaceutical companies, and diagnostic companies to find collaborators for precision medicine diagnostics projects.
• DXRX Lab Education: A collection of tailored training sessions for laboratories, focusing on enhancing testing quality and biomarker knowledge to support precision diagnostics.
• DXRX Advisory Boards: Provides pharmaceutical companies with platforms to engage with experts, gaining new insights into the commercialisation and development of therapies or companion diagnostics.
• DXRX Lab Alerts: This advanced service delivers targeted, educational messages to laboratories in the DXRX network, fostering awareness and action on essential diagnostics practices.
• Implementation and Consulting Services: Offers specialized support for the execution and advisory needs concerning precision medicine diagnostics, ensuring the alignment of diagnostic strategies with overall therapeutic goals.